Keryx Biopharmaceuticals Reports Updated Long-Term Data of Zerenex (ferric ... - PR Newswire (press release) Print
PR Newswire (press release)After the completion of a 28-day fixed dose Phase 2 clinical trial of ferric citrate in ESRD patients, 29 patients who had participated in this trial at the

... read more